Question to the Department for Work and Pensions:

To ask the Secretary of State for Work and Pensions, what recent assessment he has made of trends in the level of youth unemployment.

Answered by Pat McFadden - Secretary of State for Work and Pensions

Youth Unemployment has been rising for four years. Level of NEETS is up 250k from 2021 – 2024.

In no year since the crash have Youth Employment rates reached pre-crash levels. That's why we have introduced the Youth Guarantee and why I commissioned Alan Millburn to write his report.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department has held discussions with social media companies on content promoting anabolic steroid use and extreme body image ideals to young men.

Answered by Stephen Kinnock - Secretary of State for Wales

The Department has not held discussions with social media companies on content promoting anabolic steroid use and extreme body image ideals to young men.

However, in November 2025, the Department launched England’s first ever Men’s Health Strategy which sets out a bold vision to improve the health and wellbeing of all men and boys. The strategy recognises the role that the media plays in shaping how men interpret health information and commits to identify ways to build media literacy skills in men to help them critically assess health information and protect against misinformation that harms health.

More broadly, under the Online Safety Act, providers must take proportionate steps to reduce the risk of their services being used to facilitate illegal activity, including the unlawful supply of controlled drugs such as anabolic steroids.

The Government also supports clean competition in sport. The Department for Digital, Culture, Media and Sport supports UK Anti-Doping and UK Sport in their efforts to protect clean sport and educate athletes on the risks of performance-enhancing drugs.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what mechanisms are used by his Department to monitor the prevalence of anabolic steroid and other image and performance enhancing drug use in England.

Answered by Sharon Hodgson

The Department collects data, through the National Drug Treatment Monitoring System (NDTMS), on the number of people in structured substance misuse treatment, including those reporting a problem with anabolic steroids and other image and performance enhancing drug (IPED) use. However, people seeking help solely for steroid misuse, and not for alcohol or other drug misuse, may not be in structured treatment, depending on local commissioning arrangements, and would therefore not be captured in NDTMS. Where steroid misuse is linked to broader substance misuse, it would be recorded in NDTMS. As a result, NDTMS does not provide data on the prevalence of steroid or IPED use.

Data on anabolic steroid use is collected through the Crime Survey for England and Wales, published by the Office for National Statistics. The latest release provides an overview of the extent of, and trends in, illicit drug use in the year ending March 2025, and is available at the following link:

https://www.ons.gov.uk/peoplepopulationandcommunity/crimeandjustice/articles/drugmisuseinenglandandwales/yearendingmarch2025

Anabolic steroid use is not recognised as a distinct diagnostic category in current classification systems, which limits health services’ ability to identify, record, and monitor cases in hospital data. Although some diagnostic codes relating to steroid misuse do exist, they are broad and do not reliably capture anabolic steroid use or its associated complications. As a result, data on hospital admissions linked to anabolic steroid use and related complications is not held.

Enforcement against the illegal online sale of anabolic steroids is a matter for the Home Office under the Misuse of Drugs Act 1971. Officials in the Department of Health and Social Care work closely with the Home Office to tackle the harms that all illicit drugs cause.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department maintains data on the number of hospital admissions linked to anabolic steroid use and related complications.

Answered by Sharon Hodgson

The Department collects data, through the National Drug Treatment Monitoring System (NDTMS), on the number of people in structured substance misuse treatment, including those reporting a problem with anabolic steroids and other image and performance enhancing drug (IPED) use. However, people seeking help solely for steroid misuse, and not for alcohol or other drug misuse, may not be in structured treatment, depending on local commissioning arrangements, and would therefore not be captured in NDTMS. Where steroid misuse is linked to broader substance misuse, it would be recorded in NDTMS. As a result, NDTMS does not provide data on the prevalence of steroid or IPED use.

Data on anabolic steroid use is collected through the Crime Survey for England and Wales, published by the Office for National Statistics. The latest release provides an overview of the extent of, and trends in, illicit drug use in the year ending March 2025, and is available at the following link:

https://www.ons.gov.uk/peoplepopulationandcommunity/crimeandjustice/articles/drugmisuseinenglandandwales/yearendingmarch2025

Anabolic steroid use is not recognised as a distinct diagnostic category in current classification systems, which limits health services’ ability to identify, record, and monitor cases in hospital data. Although some diagnostic codes relating to steroid misuse do exist, they are broad and do not reliably capture anabolic steroid use or its associated complications. As a result, data on hospital admissions linked to anabolic steroid use and related complications is not held.

Enforcement against the illegal online sale of anabolic steroids is a matter for the Home Office under the Misuse of Drugs Act 1971. Officials in the Department of Health and Social Care work closely with the Home Office to tackle the harms that all illicit drugs cause.

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions his Department has had with the Home Office on enforcement against the illegal online sale of anabolic steroids.

Answered by Sharon Hodgson

The Department collects data, through the National Drug Treatment Monitoring System (NDTMS), on the number of people in structured substance misuse treatment, including those reporting a problem with anabolic steroids and other image and performance enhancing drug (IPED) use. However, people seeking help solely for steroid misuse, and not for alcohol or other drug misuse, may not be in structured treatment, depending on local commissioning arrangements, and would therefore not be captured in NDTMS. Where steroid misuse is linked to broader substance misuse, it would be recorded in NDTMS. As a result, NDTMS does not provide data on the prevalence of steroid or IPED use.

Data on anabolic steroid use is collected through the Crime Survey for England and Wales, published by the Office for National Statistics. The latest release provides an overview of the extent of, and trends in, illicit drug use in the year ending March 2025, and is available at the following link:

https://www.ons.gov.uk/peoplepopulationandcommunity/crimeandjustice/articles/drugmisuseinenglandandwales/yearendingmarch2025

Anabolic steroid use is not recognised as a distinct diagnostic category in current classification systems, which limits health services’ ability to identify, record, and monitor cases in hospital data. Although some diagnostic codes relating to steroid misuse do exist, they are broad and do not reliably capture anabolic steroid use or its associated complications. As a result, data on hospital admissions linked to anabolic steroid use and related complications is not held.

Enforcement against the illegal online sale of anabolic steroids is a matter for the Home Office under the Misuse of Drugs Act 1971. Officials in the Department of Health and Social Care work closely with the Home Office to tackle the harms that all illicit drugs cause.

Question to the HM Treasury:

To ask the Chancellor of the Exchequer, what assessment she has made of the economic impact of the off-payroll working rules (IR35) on the (a) information technology, (b) engineering, (c) the construction, (d) financial services, (e) defence and aerospace, (f) energy, (g) telecommunications, (h) life sciences (i) manufacturing, (j) professional services (k) media and creative industries, and (l) transport sectors since the extension of those rules to the private sector in April 2021.

Answered by Dan Tomlinson - Exchequer Secretary (Cabinet Office) (Jointly with HM Treasury)

I refer the Hon. Member to the written answer given to the Hon. Member for Fylde on 24 June 2026: Written questions and answers - Written questions, answers and statements - UK Parliament.

Found: Sheffield Brightside and Hillsborough) Anna Sabine (Liberal Democrat; Frome and East Somerset) Dr Neil Shastri-Hurst

Found: Dr Rose Marie Parr (Lay member) Anna Sabine (Liberal Democrat; Frome and East Somerset) Dr Neil Shastri-Hurst

Found: Sheffield Brightside and Hillsborough) Anna Sabine (Liberal Democrat; Frome and East Somerset) Dr Neil Shastri-Hurst

Found: Sabine (Liberal Democrat, Frome and East Somerset) (added 28 Oct 2024) 3 of 7 (42.9%) Dr Neil Shastri-Hurst

Found: Sabine (Liberal Democrat, Frome and East Somerset) (added 28 Oct 2024) 21 of 30 (70.0%) Dr Neil Shastri-Hurst

Found: Slaughter (Chair); Janet Daby; Sir Ashley Fox; Warinder Juss; Tessa Munt; Sarah Russell; Dr Neil Shastri-Hurst

Found: present: Andy Slaughter (Chair); Sir Ashley Fox; Warinder Juss; Tessa Munt; Sarah Russell; Dr Neil Shastri-Hurst